.svg){kind=small}
Where to Buy
High Peaks is stocked at 206 licensed dispensaries across New York and Maine, 184 of them in New York, with the deepest coverage in New York, Rochester, Syracuse, Buffalo, and Albany. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, High Peaks concentrated 43.19% of sales in Pre-Roll with year-over-year growth of 213.90% and month-over-month growth of 21.15%, while Flower held 29.18% share with 38.23% YoY and a sharper 90.62% MoM surge; Beverage accounted for 25.27% share with 40.77% YoY and 29.75% MoM, contrasting sharply with Edible at 2.22% share and declines of 50.25% YoY and 7.50% MoM. Concentrates contracted to 0.15% share with drops of 83.45% YoY and 72.08% MoM, and average price across the brand rose 21.98% YoY as Pre-Roll averaged $17.29 and Flower averaged $43.33. The mix shift toward Pre-Roll and a fast-recovering Flower, alongside Beverage expansion and shrinking Edible and Concentrates, implies deliberate focus on inhalables and ready-to-drink formats that is lifting overall velocity while pruning low-yield segments.
Positioning-wise, the 213.90% YoY and 21.15% MoM gains in Pre-Roll paired with a 90.62% MoM upswing in Flower in New York support a push toward value-accessible inhalables where rank 30 in Pre-Roll leaves headroom for share capture, while Beverage’s 29.75% MoM rise and 40.77% YoY growth diversify use occasions without diluting the core. With Edible down 50.25% YoY and Concentrates down 83.45% YoY, reallocating toward Pre-Roll/Flower could elevate the July 2026 Pre-Roll ranking from 30 and convert July’s 29.18% Flower share and 25.27% Beverage share into sustained basket presence as average price is managed 21.98% higher without stalling unit momentum. The pattern implies a pricing-and-mix strategy that leans on Pre-Roll scale and Flower recovery to improve competitive stance while Beverage acts as a secondary growth pillar and underperforming formats are deprioritized.
Competitive Landscape
High Peaks sits at rank #30 in NY Pre-Roll for July 2026, improving 36 positions year over year from #66, and rising 8 spots from April 2026 when it was #38; the brand’s peak of #26 in October 2025 marks a 4-position gap to reclaim. Against that backdrop, Ruby Farms held #1 with an 8.6% YoY sales increase while Anthem climbed from #39 to #2 on an 877.2% YoY sales surge, indicating that High Peaks’ ascent of 36 ranks YoY must accelerate to keep pace with top-tier momentum and to convert short-term rank gains into a return toward its October 2025 peak.
Notable Products
CBD/THC 1:2 Margarita (5mg CBD, 10mg THC, 12oz) posted the standout movement in July 2026 with a 32.7% month-over-month rise and held rank 3, while CBD/THC 1:2 Sparkling Strawberry Lemonade (5mg CBD, 10mg THC, 12oz) climbed 20.2% to rank 1. Sherb Wedding Cake Pre-Roll 2-Pack (1.5g) advanced 44.9% to rank 5, but five of the top ten are Pre-Roll SKUs, indicating mix breadth despite Beverage leadership at ranks 1–4. The coexistence of double-digit Beverage growth alongside a 44.9% Pre-Roll surge suggests High Peaks is leaning into a two-pillar portfolio, using fast-rising drinks to pull traffic while stabilizing basket size with concentrated Pre-Roll depth.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
